ATE77488T1 - In-vitro-testverfahren zum nachweis zellulaerer immunresponsen. - Google Patents

In-vitro-testverfahren zum nachweis zellulaerer immunresponsen.

Info

Publication number
ATE77488T1
ATE77488T1 AT87901300T AT87901300T ATE77488T1 AT E77488 T1 ATE77488 T1 AT E77488T1 AT 87901300 T AT87901300 T AT 87901300T AT 87901300 T AT87901300 T AT 87901300T AT E77488 T1 ATE77488 T1 AT E77488T1
Authority
AT
Austria
Prior art keywords
immune responses
test procedure
cellular immune
vitro test
detecting cellular
Prior art date
Application number
AT87901300T
Other languages
English (en)
Inventor
Paul Richard Wood
Leigh Austin Corner
Original Assignee
Commw Scient Ind Res Org
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commw Scient Ind Res Org filed Critical Commw Scient Ind Res Org
Application granted granted Critical
Publication of ATE77488T1 publication Critical patent/ATE77488T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866Interferon
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/811Interferon
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/863Mycobacterium

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT87901300T 1986-03-06 1987-03-05 In-vitro-testverfahren zum nachweis zellulaerer immunresponsen. ATE77488T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPH489386 1986-03-06
EP87901300A EP0296158B1 (de) 1986-03-06 1987-03-05 In-vitro-testverfahren zum nachweis zellulärer immunresponsen
PCT/AU1987/000061 WO1987005400A1 (en) 1986-03-06 1987-03-05 In vitro assay for detecting cell-mediated immune responses

Publications (1)

Publication Number Publication Date
ATE77488T1 true ATE77488T1 (de) 1992-07-15

Family

ID=3771495

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87901300T ATE77488T1 (de) 1986-03-06 1987-03-05 In-vitro-testverfahren zum nachweis zellulaerer immunresponsen.

Country Status (8)

Country Link
US (2) US5334504A (de)
EP (1) EP0296158B1 (de)
JP (1) JP2642112B2 (de)
AT (1) ATE77488T1 (de)
AU (1) AU595021B2 (de)
CA (1) CA1299099C (de)
DE (1) DE3779909T2 (de)
WO (1) WO1987005400A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766920A (en) * 1982-08-11 1998-06-16 Cellcor, Inc. Ex vivo activation of immune cells
EP0296158B1 (de) * 1986-03-06 1992-06-17 Commonwealth Scientific And Industrial Research Organisation In-vitro-testverfahren zum nachweis zellulärer immunresponsen
NZ228529A (en) * 1988-03-31 1991-07-26 Commw Scient Ind Res Org Diagnosis of mycobacterium bovis infection in a susceptible animal
US5693500A (en) * 1988-03-31 1997-12-02 Commonwealth Scientific And Industrial Research Organisation Diagnosis of Mycobacterium bovis infection
CA2011099A1 (en) * 1989-04-19 1990-10-19 Stephen C. Wardlaw Determination of lymphocyte reactivity to specific antigens in blood
WO1991003736A1 (fr) * 1989-09-08 1991-03-21 Tamio Yamauchi Procede permettant de determiner la cinetique de l'immunite
US5639623A (en) * 1989-09-08 1997-06-17 Yamauchi; Tamio Method of measuring immunokinetics
DE539610T1 (de) * 1991-10-26 1993-12-16 Torf Ets Verfahren und Zusammensetzung zur Bestimmung der Immunologischen Aktivität von aktiven Substanzen enthaltende Lösungen.
US5583713A (en) * 1994-07-22 1996-12-10 Analog Devices, Inc. Pipelined demodulation and ADC conversion scheme for disk drive servo system
US5750356A (en) * 1996-05-31 1998-05-12 Anergen, Inc. Method for monitoring T cell reactivity
GB9624456D0 (en) 1996-11-25 1997-01-15 Isis Innovation Assay method
RU2159936C2 (ru) * 1998-03-30 2000-11-27 Ариненко Руслан Юрьевич Способ выбора типа иммуномодулирующей терапии и определения прогноза исхода заболевания на основе анализа интерферонового статуса больного
DE19835721A1 (de) 1998-08-07 2000-02-10 Edi Experimentelle & Diagnosti Verfahren zur Bestimmung der Immunabwehr des Blutes sowie Testkit hierfür und Verwendung eines geeigneten Spritzenzylinders
US6297015B1 (en) * 1998-09-24 2001-10-02 Ira Shafran Crohn's disease diagnostic and treatment methods and compositions
US6150121A (en) * 1999-02-16 2000-11-21 Wisconsin Alumni Research Foundation Assessing immunological state of transplant recipients
US6316205B1 (en) * 2000-01-28 2001-11-13 Genelabs Diagnostics Pte Ltd. Assay devices and methods of analyte detection
WO2003052424A2 (en) * 2001-12-14 2003-06-26 Cambridge University Technical Services Limited Methods and means for modulating the immune response
AU2002952548A0 (en) * 2002-11-08 2002-11-21 Cellestis Limited Diagnostic assay
US7638271B2 (en) * 2003-07-31 2009-12-29 ICDDR, B: The Center for Health and Population Research Use of antibody from lymphocyte secretions to diagnose active infection
CN105717306A (zh) * 2007-03-16 2016-06-29 赛乐思迪斯有限公司 细胞介导的免疫应答检验及其试剂盒
JP5851243B2 (ja) 2008-11-30 2016-02-03 イミューサンティー インコーポレーテッドImmusanT,Inc. セリアック病の処置のための組成物および方法
US9968666B2 (en) 2009-06-12 2018-05-15 Vaccine Technologies, Incorporated Methods and compositions for promoting a cell-mediated immune response
WO2010144794A1 (en) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Baculovirus-expressed fusion polypeptide vaccines with enhanced immunogenicity and uses thereof
RU2423705C2 (ru) * 2009-06-15 2011-07-10 Седа Суреновна Григорян Способ определения индивидуальной чувствительности лейкоцитов крови людей к лекарственному препарату
US10578612B2 (en) * 2010-05-28 2020-03-03 Cellestis International Pty Ltd. Diagnostic assay
ITRM20100411A1 (it) * 2010-07-23 2012-01-24 Massimo Amicosante Uso di sequenze amminoacidiche da mycobacterium tuberculosis o dei loro corrispondenti acidi nucleici per la diagnosi e la prevenzione di infezione tubercolare, relativo kit diagnostico e vaccino.
CA2900008C (en) 2013-02-07 2025-10-07 Children's Medical Center Corporation PROTEIN ANTIGENS THAT CONFER PROTECTION AGAINST COLONIZATION AND/OR PNEUMOCOCCAL DISEASE
EP3043812A1 (de) 2013-09-10 2016-07-20 Immusant Inc. Dosierung einer glutenpeptidzusammensetzung
WO2015164722A1 (en) 2014-04-24 2015-10-29 Immusant, Inc. Compositions comprising gluten
AU2015323979A1 (en) 2014-09-29 2017-05-18 Immusant, Inc. Use of HLA genetic status to assess or select treatment of celiac disease
KR101665849B1 (ko) * 2015-01-29 2016-10-12 사단법인대한결핵협회 결핵감염 진단을 위한 항원 펩타이드 조성물 및 이의 용도

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3969497A (en) * 1971-05-05 1976-07-13 Lincoln Laboratories, Inc. Test substance for tuberculosis
GB1443425A (en) * 1972-10-25 1976-07-21 Searle & Co Interferon assay
US4745053A (en) * 1983-07-08 1988-05-17 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyojo Process for producing human interferon and method for assaying the interferon productivity of blood
DE3484329D1 (de) * 1983-07-29 1991-05-02 Univ Rockefeller Verwendung von gamma-interferon zur herstellung eines wirkstoffes in der behandlung von lepra.
US4666865A (en) * 1984-01-13 1987-05-19 Centocor, Inc. Immunoassay for biologically active human interferon-gamma employing unique monoclonal antibodies
US4675282A (en) * 1984-07-06 1987-06-23 Damon Biotech, Inc. Assay for interferon epsilon
GB8418828D0 (en) * 1984-07-24 1984-08-30 Lab Ltd Ab Ag Calf screening
US4708937A (en) * 1984-10-15 1987-11-24 Brigham & Women's Hospital Purified migration inhibitory factor also having colony stimulating factor activity
US4689397A (en) * 1985-08-12 1987-08-25 Scripps Clinic And Research Foundation Synthetic polypeptides for detecting mycobacterial infections
EP0296158B1 (de) * 1986-03-06 1992-06-17 Commonwealth Scientific And Industrial Research Organisation In-vitro-testverfahren zum nachweis zellulärer immunresponsen
US4976958A (en) * 1987-02-26 1990-12-11 Scripps Clinic And Research Foundation Mycobacterial recombinants and peptides

Also Published As

Publication number Publication date
EP0296158A4 (de) 1989-10-04
DE3779909D1 (de) 1992-07-23
DE3779909T2 (de) 1993-01-07
AU595021B2 (en) 1990-03-22
JPS63502695A (ja) 1988-10-06
JP2642112B2 (ja) 1997-08-20
US5334504A (en) 1994-08-02
EP0296158B1 (de) 1992-06-17
CA1299099C (en) 1992-04-21
EP0296158A1 (de) 1988-12-28
WO1987005400A1 (en) 1987-09-11
US5494799A (en) 1996-02-27
AU7165987A (en) 1987-09-28

Similar Documents

Publication Publication Date Title
ATE77488T1 (de) In-vitro-testverfahren zum nachweis zellulaerer immunresponsen.
EP0140379A3 (en) Method and apparatus for measuring the degree of reaction between antigens and leukocyte cellular antibodies
FI98961B (fi) Menetelmät ja määritysvälineet parodontaalisairauden aktiivisuuden ja/tai peri-implantiitin ja/tai niiden kohonneen riskin diagnosoimiseksi
ATE114673T1 (de) Modulator der anabolischen aktivität und seine verwendungen.
IT1083606B (it) Contenitore particolarmente provetta per analisi o procedure immuno chomiche ed enzimatiche e procedimento per la sua fabbricazione
FI895959A7 (fi) Koostumus, diagnostinen käyttöpakkaus ja menetelmä vasta-aineiden nope aksi toteamiseksi
ES454276A1 (es) Perfeccionamientos en un dispositivo para detectar la gona- dotropina corionica humana o su subunidad beta en la orina oel suero en la prueba de embarazo.
NO161287C (no) Homogen immunologisk analysemetode, reagensmidler og proeveinnretning for bruk ved immunoanalysebestemmelse.
IT8521902A0 (it) Procedimento e dispositivo per la misurazione degli spessori sui pezzi in prova mediante ultrasuoni.
DE2964944D1 (en) A serological method for determining the presence of neisseria gonorrhoeae antibodies in human serum, a species-specific heat stable antigen to be used in this method and a method for the preparation of that antigen
SE8004542L (sv) Diagnostiskt test
FI810007A7 (fi) Ihmisen syöpäsolujen toteaminen vasta- aineilla jotka ovat spesifisiä ihmisen syöpäsolujen tumajyväsantigeenetumajyväsantigeeneille.
JPS5294418A (en) Diluent for measuring rubella hi antibody
ES8604693A1 (es) Un metodo para detectar un anticuerpo o un antigeno contenido en una muestra de fluido de origen biologico.
JPS5292773A (en) Automatic analyzer
GB1385087A (en) Antigenic substance for testing for tuberculosis
DK414386D0 (da) Monoklonalt antistof, cellelinje til fremstilling deraf og antistoffets anvendelse
DK104988D0 (da) Fremgangsmaade og apparat til kvalitativ og/eller kvantitativ analyse af antigener, antistoffer, mikroorganismer eller andre celler
PL262516A1 (en) Method of diagnosing by laboratory tests the infection caused in particular by htlv iii virus
IT1109481B (it) Metodo radioimmunologico per la determinazione della funzione tiroidea mediante un saggio in vitro su siero del sangue
SU1082422A1 (ru) Способ определени активности интерферона в сыворотке и плазме крови
JPS51144293A (en) Continuous analysis system of urine, etc
JPS5218815A (en) Novel method of immunological clinical diagnosis by means of gel-preci pitation
SU1336703A1 (ru) Способ определения соотношения делящихся и спонтанно делящихся нуклидов в изделиях
CAO A STUDY ON THE DETECTION OF RED CELL IMMUNE ADHERENCE ACTIVITY WITH ERYTHROCYTES ENZYME-LINKED IMMUNOSORBENT ASSAY